316 related articles for article (PubMed ID: 16271105)
1. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
[TBL] [Abstract][Full Text] [Related]
2. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
[TBL] [Abstract][Full Text] [Related]
3. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.
Kakaiya RM; Whaley A; Howard-Menk C; Rami J; Papari M; Campbell-Lee S; Malecki Z
Immunohematology; 2010; 26(3):119-23. PubMed ID: 21214298
[TBL] [Abstract][Full Text] [Related]
4. Use of recombinant human erythropoietin (EPO-alfa) in a mother alloimmunized to the Js(b) antigen.
Santolaya-Forgas J; Vengalil S; Duval J; Gottmann D; Meyer W; Gauthier D; DeChristopher PJ
J Matern Fetal Med; 1999; 8(3):141-5. PubMed ID: 10338071
[TBL] [Abstract][Full Text] [Related]
5. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
6. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.
Manoura A; Korakaki E; Hatzidaki E; Saitakis E; Maraka S; Papamastoraki I; Matalliotakis E; Foundouli K; Giannakopoulou C
Pediatr Hematol Oncol; 2007; 24(1):69-73. PubMed ID: 17130116
[TBL] [Abstract][Full Text] [Related]
7. [A hemolytic transfusion reaction due to Anti-Ku antibody in a patient with Knull phenotype: the first case in Korea].
Kang MG; Lim YA; Lee KM
Korean J Lab Med; 2009 Jun; 29(3):238-42. PubMed ID: 19571622
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin.
Dhodapkar KM; Blei F
J Pediatr Hematol Oncol; 2001 Jan; 23(1):69-70. PubMed ID: 11196277
[TBL] [Abstract][Full Text] [Related]
9. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
Ovali F; Samanci N; Dağoğlu T
Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
[TBL] [Abstract][Full Text] [Related]
10. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
11. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
[TBL] [Abstract][Full Text] [Related]
12. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
Tantalo V; Rossi E; Gianotti GA; Morotti R; Zuliani G; Buscaglia M; Galligani M
Ann Ostet Ginecol Med Perinat; 1990; 111(5):321-5. PubMed ID: 2092607
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
Sainio S; Nupponen I; Kuosmanen M; Aitokallio-Tallberg A; Ekholm E; Halmesmäki E; Orden MR; Palo P; Raudaskoski T; Tekay A; Tuimala J; Uotila J; Stefanovic V
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
[TBL] [Abstract][Full Text] [Related]
14. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.
Scaradavou A; Inglis S; Peterson P; Dunne J; Chervenak F; Bussel J
J Pediatr; 1993 Aug; 123(2):279-84. PubMed ID: 8345428
[TBL] [Abstract][Full Text] [Related]
15. Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis.
Macher S; Wagner T; Rosskopf K; Reiterer F; Csapo B; Schlenke P; Klaritsch P
Transfusion; 2016 Jan; 56(1):80-3. PubMed ID: 26496681
[TBL] [Abstract][Full Text] [Related]
16. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
17. Autologous intrauterine transfusion in a case of anti-U.
Adam S; Lombaard H
Transfusion; 2016 Dec; 56(12):3029-3032. PubMed ID: 27664105
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization.
Collinet P; Subtil D; Puech F; Vaast P
Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1102-5. PubMed ID: 12423822
[TBL] [Abstract][Full Text] [Related]
19. Current clinical management of anti-Kell alloimmunization in pregnancy.
Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
[TBL] [Abstract][Full Text] [Related]
20. Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kp(b).
Bleile MJ; Rijhsinghani A; Dwyre DM; Raife TJ
Transfus Apher Sci; 2010 Dec; 43(3):281-283. PubMed ID: 20951648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
